Professor Dalia Dawoud, PhD, is the Director and CEO of PEHTA Consulting LTD. She has over 15-years’ experience as health economist, researcher and academic. Her work is largely focused on the application of health economics ad outcomes research (HEOR) in HTA and clinical guideline development. She worked at leading organisations including NICE, where she led a portfolio of HORIZON Europe projects such as HTx, IMI EHDEN and SUSTAIN HTA, and the Royal College of Physicians- London. She is widely published in the area of HEOR and health policy and serves as Associate Editor of ISPOR journal Value in Health and as Director on ISPOR Board of Directors (2023-2026). She is also a member of ISPOR AI Working Group, Living HTA Working Group and Task Force on using GenAI n systematic reviews. She also holds Professor position at the Faculty of Pharmacy, Cairo University.